Identification and selection of cardiomyocytes during human embryonic stem cell differentiation
- PMID: 17435178
- DOI: 10.1096/fj.05-5711com
Identification and selection of cardiomyocytes during human embryonic stem cell differentiation
Abstract
Human embryonic stem cells (hESC) are pluripotent lines that can differentiate in vitro into cell derivatives of all three germ layers, including cardiomyocytes. Successful application of these unique cells in the areas of cardiovascular research and regenerative medicine has been hampered by difficulties in identifying and selecting specific cardiac progenitor cells from the mixed population of differentiating cells. We report the generation of stable transgenic hESC lines, using lentiviral vectors, and single-cell clones that express a reporter gene (eGFP) under the transcriptional control of a cardiac-specific promoter (the human myosin light chain-2V promoter). Our results demonstrate the appearance of eGFP-expressing cells during the differentiation of the hESC as embryoid bodies (EBs) that can be identified and sorted using FACS (purity>95%, viability>85%). The eGFP-expressing cells were stained positively for cardiac-specific proteins (>93%), expressed cardiac-specific genes, displayed cardiac-specific action-potentials, and could form stable myocardial cell grafts following in vivo cell transplantation. The generation of these transgenic hESC lines may be used to identify and study early cardiac precursors for developmental studies, to robustly quantify the extent of cardiomyocyte differentiation, to label the cells for in vivo grafting, and to allow derivation of purified cell populations of cardiomyocytes for future myocardial cell therapy strategies.
Similar articles
-
Connexin 40 promoter-based enrichment of embryonic stem cell-derived cardiovascular progenitor cells.Cells Tissues Organs. 2008;188(1-2):62-9. doi: 10.1159/000119408. Epub 2008 Feb 29. Cells Tissues Organs. 2008. PMID: 18305379
-
Selection of ventricular-like cardiomyocytes from ES cells in vitro.FASEB J. 2000 Dec;14(15):2540-8. doi: 10.1096/fj.00-0002com. FASEB J. 2000. PMID: 11099473
-
Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system.Stem Cells Dev. 2008 Aug;17(4):825-36. doi: 10.1089/scd.2007.0233. Stem Cells Dev. 2008. PMID: 18788934
-
Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.J Control Release. 2006 Nov 28;116(2):211-8. doi: 10.1016/j.jconrel.2006.06.027. Epub 2006 Jun 29. J Control Release. 2006. PMID: 17005287 Review.
-
Cardiovascular therapeutic aspects of cell therapy and stem cells.Ann N Y Acad Sci. 2006 Oct;1080:415-25. doi: 10.1196/annals.1380.030. Ann N Y Acad Sci. 2006. PMID: 17132798 Review.
Cited by
-
Functional cardiac tissue engineering.Regen Med. 2012 Mar;7(2):187-206. doi: 10.2217/rme.11.122. Regen Med. 2012. PMID: 22397609 Free PMC article. Review.
-
Injectable cardiac tissue engineering for the treatment of myocardial infarction.J Cell Mol Med. 2010 May;14(5):1044-55. doi: 10.1111/j.1582-4934.2010.01046.x. Epub 2010 Feb 27. J Cell Mol Med. 2010. PMID: 20193036 Free PMC article. Review.
-
Stem cells and their derivatives: a renaissance in cardiovascular translational research.J Cardiovasc Transl Res. 2011 Feb;4(1):66-72. doi: 10.1007/s12265-010-9235-1. J Cardiovasc Transl Res. 2011. PMID: 21061105 Review.
-
Adhesion proteins, stem cells, and arrhythmogenesis.Cardiovasc Toxicol. 2008 Mar;8(1):1-13. doi: 10.1007/s12012-007-9008-5. Epub 2008 Jan 5. Cardiovasc Toxicol. 2008. PMID: 18176845 Free PMC article. Review.
-
Label-free identification and characterization of human pluripotent stem cell-derived cardiomyocytes using second harmonic generation (SHG) microscopy.J Biophotonics. 2012 Jan;5(1):57-66. doi: 10.1002/jbio.201100077. Epub 2011 Nov 15. J Biophotonics. 2012. PMID: 22083829 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources